Heart drug tested to block cancer in High-Risk bowel disease patients
NCT ID NCT04767984
Summary
This study is testing if atorvastatin, a common cholesterol-lowering drug, can help prevent colon cancer in people with long-term ulcerative colitis who have a specific genetic change. It involves 42 adults who will take either atorvastatin or a placebo pill daily for one year. Researchers will check colon tissue samples before and after treatment to see if the drug reduces the presence of a cancer-linked protein.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
-
University of Kansas Cancer Center
Kansas City, Kansas, 66160, United States
Conditions
Explore the condition pages connected to this study.